Cullinan Therapeutics, Inc 10-Q for FY2022 Q2
Cullinan Therapeutics, Inc. (CGEM)
10-Q
2022-08-10
For: 2022-06-30
View Original
Added on
April 04, 2026
About this 10-Q
Cullinan Therapeutics, Inc filed this 10-Q on August 10, 2022, covering the quarter ended June 30, 2022 (FY2022 Q2).
Headline figures
Quarter ended June 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- compared with $0 a year earlier
- Net income
- $174.9M
- compared with a net loss of $15.64M a year earlier
- Diluted EPS
- $3.77
- compared with -$0.36 a year earlier